Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Frankfurt - Delayed Quote EUR

Abeona Therapeutics Inc. (PCJ.F)

Compare
4.8400
-0.0800
(-1.63%)
At close: February 28 at 8:07:15 AM GMT+1
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
--
3,500
1,414
3,000
10,000
Cost of Revenue
--
1,605
450
--
--
Gross Profit
--
1,895
964
3,000
--
Operating Expense
60,748
50,095
46,221
60,370
58,504
Operating Income
-60,748
-48,200
-45,257
-57,370
-48,504
Net Non Operating Interest Income Expense
731
1,699
-305
-3,616
-2,814
Other Income Expense
-11,015
-7,687
5,866
-23,950
-32,916
Pretax Income
-71,032
-54,188
-39,696
-84,936
-84,234
Net Income Common Stockholders
-71,032
-54,188
-43,478
-84,936
-84,234
Diluted NI Available to Com Stockholders
-71,032
-54,188
-43,478
-84,936
-84,234
Basic EPS
-2.05
-2.53
-5.53
-21.50
-22.75
Diluted EPS
-2.05
-2.53
-5.53
-21.50
-22.75
Basic Average Shares
35,301.7210
21,380.4760
7,861.5150
3,937.6760
3,706.5420
Diluted Average Shares
35,301.7210
21,380.4760
7,861.5150
3,937.6760
3,706.5420
Total Operating Income as Reported
-60,748
-47,135
-50,915
-89,836
-81,420
Total Expenses
60,748
51,700
46,671
60,370
58,504
Net Income from Continuing & Discontinued Operation
-71,032
-54,188
-39,696
-84,936
-84,234
Normalized Income
-59,272
-43,558
-45,421
-60,971
-51,318
Interest Income
3,966
2,117
431
40
1,301
Interest Expense
3,235
418
736
3,656
4,115
Net Interest Income
731
1,699
-305
-3,616
-2,814
EBIT
-67,797
-53,770
-38,960
-81,280
-80,119
EBITDA
-64,945
-50,572
-34,383
-76,816
-74,518
Reconciled Cost of Revenue
--
1,605
450
--
--
Reconciled Depreciation
2,852
3,198
4,577
4,464
5,601
Net Income from Continuing Operation Net Minority Interest
-71,032
-54,188
-39,696
-84,936
-84,234
Total Unusual Items Excluding Goodwill
-11,760
-10,630
5,725
-23,965
-32,916
Total Unusual Items
-11,760
-10,630
5,725
-23,965
-32,916
Normalized EBITDA
-53,185
-39,942
-40,108
-52,851
-41,602
12/31/2020 - 1/30/2004

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers